Research ArticleCancer

Targeted immunotherapy for HER2-low breast cancer with 17p loss

See allHide authors and affiliations

Science Translational Medicine  10 Feb 2021:
Vol. 13, Issue 580, eabc6894
DOI: 10.1126/scitranslmed.abc6894

Log in to view full text

Log in through your institution

Log in through your institution

Stay Connected to Science Translational Medicine

Navigate This Article